RCAN1 and Down syndrome: Nevertheless, given that the blood PAI-1 levels in Down syndrome individuals are lower than in controls [36] we hypothesize that the attenuation of the NGF-induced PAI-1 by overexpression of DYRK1A and RCAN1 due to trisomy 21 may be relevant to several Down syndrome features.